UAE Insulin Delivery Devices Market By Product Type (Pens {Disposable v/s Reusable}, Pumps {External/Tethered Pumps v/s Patch Pumps}, Pen Needles {Standard Pen Needles v/s Safety Pen Needles}, Others) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online, Others) By End User (Hospitals & Clinics, Homecare, Others), By Region, Competition Forecast & Opportunities, 2027
UAE insulin delivery devices market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027, on the account of increasing demand for better insulin administrations. Rising instances of diabetes among the population are also driving the growth of the UAE insulin delivery devices market in the upcoming five years. Technological advancement in medical devices and their growing imports in the country also influences the growth of the UAE insulin delivery devices market in the next five years.
Insulin delivery devices are self-explanatory medical equipment that is utilized for the easier administration, timely, and swift facilitation of insulin. Syringes, pens, pumps, and jet injectors are some of the various pieces of equipment that are included in insulin delivery devices. The growing geriatric population and surge in the demand for better drug administration devices & equipment also facilitate the growth of the UAE insulin delivery devices market in the future five years.
Increasing Instances of Diabetes Drive Market Growth
Increasing instances of diabetes among the population of the United Arab Emirates is the major factor aiding the demands for insulin delivery devices, diabetes drugs, and other pharmaceutical and therapeutic products, thereby driving the growth of the UAE insulin delivery devices market in the upcoming five years. In the year 2021, among every 1000 population mark of the country, over 990 people suffer from diabetes. The geriatric population is highly susceptible to diabetic conditions and the risks increase due to prolonged consumption of sugary food.
Moreover, with insulin delivery devices, proper monitoring of the dosage and timed administration can be achieved thus aiding the growth of the market. One in every 5 people aged over 69 years suffers from diabetes in the country. By 2019, over 19% of the adult population aged between 20 years to 79 years were suffering from type II diabetes. Diabetic patients are rapidly growing in the country, due to changing lifestyle of the population as well as the growing immigration of the populations from various countries.
Growing Investment In Healthcare Promises Growth
The healthcare industry in the country is ever-expanding and it is anticipated to aid the growth of the UAE insulin delivery devices market in the upcoming five years. Rising investments in the healthcare sector by the government, inviting foreign direct investments along with the expenses by the population with their rising disposable income further substantiate the growth of the healthcare industry along with the growth of the UAE insulin delivery devices market in the future five years. In the year 2019, UAE healthcare expenditure was 4.27% of its GDP.
Moreover, government insurance plans toward the affordability of medical devices like insulin delivery devices also facilitate the growth of the UAE insulin delivery devices market in the future five years. In June 2015, the UAE government launched a new health insurance program in Dubai to support nationals not covered under any other government-funded health insurance scheme. The Dubai Health Authority (DHA) announced in June 2016 that all Dubai residents should be covered by health insurance; this will be tied to the renewal and issuance of their UAE residence visas that aided the immigrant population in Dubai too.
Market Segmentation
The UAE insulin delivery devices market is segmented by product type, distribution channel, end-user, competitional landscape, and regional distribution. Based on product type, the market is further segmented into pens, pumps, pen needles, and others. Pens are of two types, disposable, and reusable. Pumps are also of two types external/tethered pumps and patch pumps. Pen needles are either standard pen needles or safety pen needles. By distribution channel, the market is fragmented into hospital pharmacies, retail pharmacies, online, and others. Based on end users, the market is bifurcated into hospitals & clinics, homecare, and others. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among Abu Dhabi, Dubai, Sharjah, rest of UAE.
Company Profile
Abbott Laboratories, S.A., Roche Diabetes Care Middle East, Julphar Pharmaceuticals, Medtronic Meta FZ-LLC, Novo Nordisk Pharma Gulf FZ- LLC, among others, is a partial list of major market players of the companies responsible for the growth of UAE insulin delivery devices market.
Report Scope:
In this report, UAE insulin delivery devices market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in UAE insulin delivery devices market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
Insulin delivery devices are self-explanatory medical equipment that is utilized for the easier administration, timely, and swift facilitation of insulin. Syringes, pens, pumps, and jet injectors are some of the various pieces of equipment that are included in insulin delivery devices. The growing geriatric population and surge in the demand for better drug administration devices & equipment also facilitate the growth of the UAE insulin delivery devices market in the future five years.
Increasing Instances of Diabetes Drive Market Growth
Increasing instances of diabetes among the population of the United Arab Emirates is the major factor aiding the demands for insulin delivery devices, diabetes drugs, and other pharmaceutical and therapeutic products, thereby driving the growth of the UAE insulin delivery devices market in the upcoming five years. In the year 2021, among every 1000 population mark of the country, over 990 people suffer from diabetes. The geriatric population is highly susceptible to diabetic conditions and the risks increase due to prolonged consumption of sugary food.
Moreover, with insulin delivery devices, proper monitoring of the dosage and timed administration can be achieved thus aiding the growth of the market. One in every 5 people aged over 69 years suffers from diabetes in the country. By 2019, over 19% of the adult population aged between 20 years to 79 years were suffering from type II diabetes. Diabetic patients are rapidly growing in the country, due to changing lifestyle of the population as well as the growing immigration of the populations from various countries.
Growing Investment In Healthcare Promises Growth
The healthcare industry in the country is ever-expanding and it is anticipated to aid the growth of the UAE insulin delivery devices market in the upcoming five years. Rising investments in the healthcare sector by the government, inviting foreign direct investments along with the expenses by the population with their rising disposable income further substantiate the growth of the healthcare industry along with the growth of the UAE insulin delivery devices market in the future five years. In the year 2019, UAE healthcare expenditure was 4.27% of its GDP.
Moreover, government insurance plans toward the affordability of medical devices like insulin delivery devices also facilitate the growth of the UAE insulin delivery devices market in the future five years. In June 2015, the UAE government launched a new health insurance program in Dubai to support nationals not covered under any other government-funded health insurance scheme. The Dubai Health Authority (DHA) announced in June 2016 that all Dubai residents should be covered by health insurance; this will be tied to the renewal and issuance of their UAE residence visas that aided the immigrant population in Dubai too.
Market Segmentation
The UAE insulin delivery devices market is segmented by product type, distribution channel, end-user, competitional landscape, and regional distribution. Based on product type, the market is further segmented into pens, pumps, pen needles, and others. Pens are of two types, disposable, and reusable. Pumps are also of two types external/tethered pumps and patch pumps. Pen needles are either standard pen needles or safety pen needles. By distribution channel, the market is fragmented into hospital pharmacies, retail pharmacies, online, and others. Based on end users, the market is bifurcated into hospitals & clinics, homecare, and others. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among Abu Dhabi, Dubai, Sharjah, rest of UAE.
Company Profile
Abbott Laboratories, S.A., Roche Diabetes Care Middle East, Julphar Pharmaceuticals, Medtronic Meta FZ-LLC, Novo Nordisk Pharma Gulf FZ- LLC, among others, is a partial list of major market players of the companies responsible for the growth of UAE insulin delivery devices market.
Report Scope:
In this report, UAE insulin delivery devices market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- UAE Insulin Delivery Devices Market, By Product Type:
- Pens
- Disposable
- Reusable
- Pumps
- External/Tethered Pumps
- Patch Pumps
- Pen Needles
- Standard Pen Needles
- Safety Pen Needles
- Others
- UAE Insulin Delivery Devices Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online
- Others
- UAE Insulin Delivery Devices Market, By End Users:
- Hospitals & Clinics
- Homecare
- Others
- UAE Insulin delivery devices Market, By Region:
- Abu Dhabi
- Dubai
- Sharjah
- Rest of UAE
Company Profiles: Detailed analysis of the major companies present in UAE insulin delivery devices market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
2. RESEARCH METHODOLOGY
3. IMPACT OF COVID-19 ON UAE INSULIN DELIVERY DEVICES MARKET
4. EXECUTIVE SUMMARY
5. VOICE OF CUSTOMER
6. UAE INSULIN DELIVERY DEVICES MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type (Pens, Pumps, Pen Needles, Others)
6.2.2. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online, Others)
6.2.3. By End User (Hospitals & Clinics, Homecare, Others)
6.2.4. By Region
6.2.5. By Company (2021)
6.3. Product Market Map
7. UAE INSULIN DELIVERY PENS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type (Disposable v/s Reusable)
7.2.2. By Distribution Channel
7.2.3. By End User
8. UAE INSULIN DELIVERY PUMPS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type (External/Tethered Pumps v/s Patch Pumps)
8.2.2. By Distribution Channel
8.2.3. By End User
9. UAE INSULIN DELIVERY PEN NEEDLES MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type (Standard Pen Needles v/s Safety Pen Needles)
9.2.2. By Distribution Channel
9.2.3. By End User
10. MARKET DYNAMICS
10.1. Drivers
10.2. Challenges
11. MARKET TRENDS & DEVELOPMENTS
12. POLICY & REGULATORY LANDSCAPE
13. IMPORT-EXPORT ANALYSIS
14. UAE ECONOMIC PROFILE
15. COMPETITIVE LANDSCAPE
15.1. Abbott Laboratories, S.A.
15.2. Roche Diabetes Care Middle East
15.3. Julphar Pharmaceuticals
15.4. Medtronic Meta FZ-LLC
15.5. Novo Nordisk Pharma Gulf FZ- LLC
16. STRATEGIC RECOMMENDATIONS
(Note: The companies list can be customized based on the client requirements.)
2. RESEARCH METHODOLOGY
3. IMPACT OF COVID-19 ON UAE INSULIN DELIVERY DEVICES MARKET
4. EXECUTIVE SUMMARY
5. VOICE OF CUSTOMER
6. UAE INSULIN DELIVERY DEVICES MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type (Pens, Pumps, Pen Needles, Others)
6.2.2. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online, Others)
6.2.3. By End User (Hospitals & Clinics, Homecare, Others)
6.2.4. By Region
6.2.5. By Company (2021)
6.3. Product Market Map
7. UAE INSULIN DELIVERY PENS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type (Disposable v/s Reusable)
7.2.2. By Distribution Channel
7.2.3. By End User
8. UAE INSULIN DELIVERY PUMPS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type (External/Tethered Pumps v/s Patch Pumps)
8.2.2. By Distribution Channel
8.2.3. By End User
9. UAE INSULIN DELIVERY PEN NEEDLES MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type (Standard Pen Needles v/s Safety Pen Needles)
9.2.2. By Distribution Channel
9.2.3. By End User
10. MARKET DYNAMICS
10.1. Drivers
10.2. Challenges
11. MARKET TRENDS & DEVELOPMENTS
12. POLICY & REGULATORY LANDSCAPE
13. IMPORT-EXPORT ANALYSIS
14. UAE ECONOMIC PROFILE
15. COMPETITIVE LANDSCAPE
15.1. Abbott Laboratories, S.A.
15.2. Roche Diabetes Care Middle East
15.3. Julphar Pharmaceuticals
15.4. Medtronic Meta FZ-LLC
15.5. Novo Nordisk Pharma Gulf FZ- LLC
16. STRATEGIC RECOMMENDATIONS
(Note: The companies list can be customized based on the client requirements.)
